Touting nine-figure deal package, Pfizer extends collaboration with AI partner
CytoReason Extends multi-Year Partnership with Pfizer
Epic hits a crossroads, judge rules on UnitedHealth’s Change bid, & Meta faces health data pressure
CytoReason Shoots For $110M Net With Pfizer Partnership
CytoReason and Pfizer agree deal worth up to $110M for AI drug discovery and development
Sept. 20 Quick Takes: Rocket gains gene therapy via Renovacor takeout
CytoReason announces expanded collaboration with Pfizer
CytoReason and Pfizer ink $110 million AI deal
CytoReason’s AI Earns Pfizer Extension Deal
CytoReason Announces Expanded Collaboration Deal with Pfizer
